Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 1/20 | 0.36 |
| ▸ | HTR2B | P41595 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.31 |
| ▸ | ITGB2 | P05107 | 1/20 | 0.31 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.31 |
| ▸ | ITGAL | P20701 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30563750 | 1.00 | HTR2C (0.36) | HTR2CHTR2BKDM4EMEN1ALDH1A1 | |
| SCHEMBL4744946 | 0.78 | ABCG2 (0.33) | HTR2CHTR2BABCG2ITGB2ICAM1 | |
| SCHEMBL9882907 | 0.76 | ITGB2 (0.43) | HTR2CHTR2BITGB2ICAM1ITGAL | |
| Cycloheptane SCHEMBL29003966 | 0.68 | CYP2B6 (0.41) | HTR2CHTR2BKDM4EMEN1ALDH1A1 | |
| Cyclopentane SCHEMBL997321 | 0.68 | CYP2B6 (0.41) | HTR2CHTR2BKDM4EMEN1ALDH1A1 | |
| SCHEMBL2289180 | 0.67 | CYP2B6 (0.43) | HTR2CHTR2BKDM4EMEN1ALDH1A1 | |
| SCHEMBL9208 | 0.67 | CYP2B6 (0.43) | HTR2CHTR2BKDM4EMEN1ALDH1A1 | |
| SCHEMBL2281562 | 0.67 | CYP2B6 (0.43) | HTR2CHTR2BKDM4EMEN1ALDH1A1 | |
| SCHEMBL29364609 | 0.67 | CYP2B6 (0.43) | HTR2CHTR2BKDM4EMEN1ALDH1A1 | |
| SCHEMBL11135785 | 0.67 | CYP2B6 (0.43) | HTR2CHTR2BKDM4EMEN1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 370 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113861128-A | Polymerizable compound and optically anisotropic body | 江苏创拓新材料有限公司 | 2021-12-31 | — | — | CN | claimed |
| EP-1852420-B1 | Indole compounds for treating respiratory disorders | ONO PHARMACEUTICAL CO (JP) | 2012-10-17 | — | — | EP | claimed |
| US-8153625-B2 | Nitrogen-containing heterocyclic compounds and medicinal use thereof | ONO PHARMACEUTICAL CO., LTD. (JP) | 2012-04-10 | — | — | US | claimed |
| US-7759336-B2 | Nitrogen-containing heterocyclic compounds and medicinal use thereof | ONO PHARMACEUTICAL CO., LTD. (JP) | 2010-07-20 | — | — | US | claimed |
| US-12600730-B2 | Substituted cyclopenta[c]pyrroles as ABHD6 antagonists | ONO PHARMACEUTICAL CO., LTD. (JP) | 2026-04-14 | — | — | US | disclosed |
| US-20260083735-A1 | ABHD6 ANTAGONIST | ONO PHARMACEUTICAL CO., LTD. (JP) | 2026-03-26 | — | — | US | disclosed |
| CN-121586713-A | Quinoline derivatives and pharmaceutical compositions thereof for the treatment of diseases | 百济神州(苏州)生物科技有限公司 | 2026-02-27 | — | — | CN | disclosed |
| EP-4596555-A1 | ABHD6 ANTAGONIST | ONO Pharmaceutical Co., Ltd. (JP) | 2025-08-06 | — | — | EP | disclosed |
| CN-114948963-B | Benzolactam compounds as protein kinase inhibitors | 大冢制药株式会社 | 2025-05-27 | — | — | CN | disclosed |
| CN-118984826-A | Method for preparing compounds comprising 2, 5-dihydrobenzoxazepine structures by photochemical rearrangement | 巴黎综合理工学院 | 2024-11-19 | — | — | CN | disclosed |
| CN-118984826-A | Method for preparing compounds comprising 2, 5-dihydrobenzoxazepine structures by photochemical rearrangement | 巴黎综合理工学院 | 2024-11-19 | — | — | CN | disclosed |
| CN-114605350-B | Polymerizable compound, polymerizable composition containing same, and optically anisotropic body | 江苏创拓新材料有限公司 | 2024-09-13 | — | — | CN | disclosed |
| WO-1996017833-A1 | BICYCLIC FIBRINOGEN ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1996-06-13 | — | — | WO | disclosed |
| EP-0593603-A1 | BICYCLIC FIBRINOGEN ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1994-04-27 | — | — | EP | disclosed |
| WO-1993000095-A2 | BICYCLIC FIBRINOGEN ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1993-01-07 | — | — | WO | disclosed |
| US-5135927-A | 2-chloro-4-trifluoromethylthiazol-5-carboxylic acid | CIBA-GEIGY CORPORATION (US) | 1992-08-04 | — | — | US | disclosed |
| US-4992434-A | Prevention of infestation of plants by phytopathogenic microorganisms | CIBA-GEIGY CORPORATION (US) | 1991-02-12 | — | — | US | disclosed |
| US-4504663-A | ANALGESIC, ANTIDEPRESSANT | DELALANDE S.A. (FR) | 1985-03-12 | — | — | US | disclosed |
| US-4431851-A | ANALGESICS, ANTIDEPRESSANTS | DELALANDE S.A. (FR) | 1984-02-14 | — | — | US | disclosed |
| US-4386090-A | ANALGESICS, ANTIDEPRESSANTS | DELALANDE S.A. (FR) | 1983-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12600730-B2 | Substituted cyclopenta[c]pyrroles as ABHD6 antagonists | ABHD6, ABHD16A, HDHD5 | HTR2C 2994/4885HTR2B 4330/4885KDM4E 1505/4885 |
| US-20260083735-A1 | ABHD6 ANTAGONIST | ABHD6, ABHD16A, ABHD12 | HTR2C 2982/4885HTR2B 3780/4885KDM4E 2124/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.